Radiofrequency Ablation Systems Market to Witness Remarkable Growth; Increasing Prevalence of Chronic Diseases to Support it, says Fortune Business Insights

The study is titled, “Radiofrequency Ablation Systems Market: Global Market Analysis, Insights, and Forecasts, 2019 – 2025.” The market, as per study, will exhibit growth at a promising CAGR on account of rising prevalence of both cardiovascular and chronic diseases around the world.

Gradual Shift Towards Minimally Invasive Procedures Fuels Demand for Radiofrequency Ablation Devices

In 2017, a clinical research stated that radiofrequency ablation therapies increases the probability of curing cancer by an estimated percentage of 40.0%. In addition to this, nearly 60% of cancer patients undergo radiotherapies. Radiofrequency ablation process destroys the tissues that cause cancer and using this non-surgical method also destroys the nerves that sends pain signals to the brain. Thus, patient preference for radiofrequency ablation is increasing and this will drive the market in the coming years.

The rising geriatric population and their susceptibility towards various chronic and cardiovascular diseases are boosting the global market for radiofrequency ablation systems market.  Besides this, patients are gradually shifting to minimally invasive procedures from conventional procedures and this will help the market earn more revenues during the forecast period.

Sample PDF [email protected] https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/radiofrequency-ablation-systems-market-100213

Key players leading the Global Radiofrequency Ablation Systems Market include

• Johnson & Johnson Services, Inc.,
• RF MEDICAL,
• AtriCure, Inc.,
• ENDO-FLEX GmbH,
• Bramsys Indústria e Comércio Ltda.,
• Gynesonics, Inc.,
• Medtronic,
• Boston Scientific Corporation,
• Hologic Inc.,
• RZ Medizintechnik,
• Sutter Medizintechnik GmbH,
• AngioDynamics,
• Stryker,

Gradual Shift Towards Minimally Invasive Procedures Fuels Demand for Radiofrequency Ablation Devices

In 2017, a clinical research stated that radiofrequency ablation therapies increases the probability of curing cancer by an estimated percentage of 40.0%. In addition to this, nearly 60% of cancer patients undergo radiotherapies. Radiofrequency ablation process destroys the tissues that cause cancer and using this non-surgical method also destroys the nerves that sends pain signals to the brain. Thus, patient preference for radiofrequency ablation is increasing and this will drive the market in the coming years.

Segmentation

By Product

• Unipolar Radiofrequency Ablation Systems

• Bipolar Radiofrequency Ablation Systems

By Application

• Pain Management

• Oncology

• Others

By End User

• Hospitals

• Clinics

• Ambulatory Surgery Centres

• Others

By Geography

• North America (USA and Canada)

• Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)

• Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)

• Latin America (Brazil, Mexico and Rest of Latin America)

• Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)